Pilot study on chronic rhinosinusitis in order to evaluate efficacy and tolerability of a standard antibiotic treatment (Amoxicillin and Clavulanic Acid) associated to an homeopathic complex (Dr. Reckeweg R1);Studio pilota sulle rinosinusiti croniche per valutare l'efficacia e la tollerabilità di un trattamento antibiotico standard (Amoxicillina e acido Clavulanico) associato a un complesso omeopatico (Dr. Reckeweg R1)

Rivista Italiana di Otorinolaringologia Audiologia e Foniatria

Volumn 25, Issue 2-4, 2005, Pages 109-117

  Ricciotti, F ^a   Bernardini, C ^a   D'Aco, L ^a   Giannuzzi, A L ^a   Passali G C ^a   Passàli, Desiderio ^a  

^a UNIVERSITY OF SIENA   (Italy)

Author keywords

Chronic rhinosinusitis; Dr. Reckeweg R1; Rhinorrhoea

Indexed keywords

AMOXICILLIN; CLAVULANIC ACID;

ANTIBIOTIC THERAPY; ARTICLE; ASTHENIA; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE EXACERBATION; DRUG EFFICACY; DRUG TOLERABILITY; EVALUATION; HOMEOPATHY; HUMAN; NOSE OBSTRUCTION; PILOT STUDY; QUALITY OF LIFE; RHINORRHEA; RHINOSINUSITIS;

EID: 33745095306     PISSN: 03921360     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (16)

1. BELLAVITE P.: L'omeopatia è placebo? Medicina Naturale (in press novembre 2005) in:www.fondazionericci.it/.../Bellavite_ Lancet_e_l_Omeopatia_Medicina_Naturale_nov_2005.pdf.
2. BELLUSSI L., MARCUCCI L.: Antibiotici in otorinolaringoiatria: profilassi e terapia. Otorinolaringol Ped. 2:51, 1998.
3. EDITORIAL: The end of homeopathy, Lancet, 366:690, 2005.
4. HEGER M., RILEY D.S., HAIDVOGL M.: International integrative primary care outcomes study (IIPCOS-2): an international research project of homeopathy in primary care. Br Homeopath J 89 Suppl 1:S10-3, 2000.
5. JMP: Statistical Discovery Software (computer program, version 4). Cary North Carolina: SAS Institute Inc, 2000.
6. KENNEDY D.W.: International Conference on sinus disease: terminology, staging and therapy. Annalis of Otology, Rhinology Laryngology (Suppl 167) 104:1-31, 1995.
7. KLEIJEN J., KNIPSCHILD P., RIET T. G.: Clinical trial of homeopathy. British Medical Journal 302:316, 1991.
8. PATERSON C., DIEPPE P.: Characteristic and incidental (placebo) effects in complex interventions such as acupuncture, Br.Med.J., 330:1202-1205, 2005.
9. PINCUS T., SWEARINGEN C., WOLFE F.: Toward a Multidimensional Health Assessment Questionnaire (MDHAQ). Arthritis & Rheumatism 42, (10):2220-2230, 1999.
10. PRANDELLI T.: Analisi repertoriale di alcuni complessi omeopatici e razionale del loro utilizzo. Data on file. IMO, Trezzano Rosa (Mi) 1999.
11. REGIONE LOMBARDIA.: Decreto Direzione Generale Sanita'n. 14616 del 06/10/2005 Atto n. 884. Approvazione, con relativo finanziamento, degli studi, delle ricerche e delle sperimentazioni cliniche di Medicina Complementare presentati da enti pubblici elo privati, da professionisiti singoli ed associati e da società scientifiche, promossi con la DGR. VII/13235 del 9.6.2003, in attuazione al PSSR 2002-2004.
12. REGIONE TOSCANA: Campagna di informazione per le Medicine Complementari. In: www.sanita.toscana.it/ campagne/campagna_medicine_complementari.shtml (Footnotes).
13. SCOTT J., HUSKISSON E.G.: Vertical or horizontal visual analogue scales. Ann Rheum Dis 38(6):560, 1979.
14. SHANG A., HUWILER-MÜNTENER K., NARTEY L., JÜNI P., DÖRIG S., STERNE J.A.C., PEWSNER D., EGGER M.: Are the clinical effects of homoeopathy placebo effects? Comparative study of placebo-controlled trials of homoeopathy and allopathy, Lancet 366:726-732, 2005.
15. SIMON R.: Optimal two-stage designs for phase II clinical trials. Controlled Clinical Trials 10:1-10, 1989.
16. WEATHERLEY-JONES E., THOMPSON E.A., THOMAS K.J.: The placebo-controlled trial as a test of complementary and alternative medicine: observations from research experience of idividualised homeopathic treatment. Homeopathy, 93:186-189, 2004.